Nagashima, Kazuki http://orcid.org/0000-0002-8593-136X
Zhao, Aishan
Atabakhsh, Katayoon
Bae, Minwoo http://orcid.org/0000-0002-0313-5520
Blum, Jamie E.
Weakley, Allison
Jain, Sunit http://orcid.org/0000-0002-5888-3702
Meng, Xiandong
Cheng, Alice G.
Wang, Min
Higginbottom, Steven
Dimas, Alex
Murugkar, Pallavi
Sattely, Elizabeth S. http://orcid.org/0000-0002-7352-859X
Moon, James J. http://orcid.org/0000-0001-8246-931X
Balskus, Emily P. http://orcid.org/0000-0001-5985-5714
Fischbach, Michael A. http://orcid.org/0000-0003-3079-8247
Article History
Received: 25 April 2022
Accepted: 13 July 2023
First Online: 16 August 2023
Competing interests
: Stanford University and the Chan Zuckerberg Biohub have patents pending for microbiome technologies on which the authors are co-inventors. M.A.F. is a cofounder and director of Federation Bio and Kelonia, a cofounder of Revolution Medicines and a member of the scientific advisory boards of the Chan Zuckerberg Initiative and NGM Bio. The remaining authors declare no competing interests.